Carcinotech

📍 Edinburgh, United Kingdom🗓 Founded 2018👥 11 employees💰 Last funded Jan 2024
Biotechnology Research🌐 carcinotech.com
Website LinkedIn
Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3D™ bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Carcinotech?
Carcinotech has 1 investors on record on gritt.io and 1 late-stage investors.
When did Carcinotech last raise funding?
The most recent investment in Carcinotech recorded on gritt.io was in January 2024.
When was Carcinotech founded?
Carcinotech was founded in 2018.
What industry is Carcinotech in?
Carcinotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Carcinotech based?
Carcinotech is headquartered in Edinburgh, United Kingdom.